Hydroxyflavanones as appetite stimulants

US10561633B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10561633-B2
Application numberUS-201515329062-A
CountryUS
Kind codeB2
Filing dateJul 26, 2015
Priority dateJul 30, 2014
Publication dateFeb 18, 2020
Grant dateFeb 18, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for reducing serotonin levels in a mammal in need thereof comprising orally administering to the mammal a dose of about 0.03 μg/kg to about 3 mg/kg of a compound selected from the group consisting of: a salt thereof, and mixtures thereof. 2. The method of claim 1 , wherein the compound is administered as an orally consumable medicament. 3. The method of claim 2 , wherein the orally consumable medicament comprises: (i) at least one compound selected from the group consisting of: a salt thereof, and mixtures thereof, (ii) at least one solid carrier, and (iii) one or more flavorings, with the proviso that the sum of components (i), (ii) and (iii), together with any further ingredients, is 100% by weight, based on the total amount of the medicament. 4. The method of claim 1 , wherein countercations of the salts are selected from the group consisting of ammonium, trialkylammonium, sodium, potassium, magnesium, calcium, and mixtures thereof. 5. The method of claim 1 , wherein the compound is administered as an orally consumable foodstuff consumed for nourishment or pleasure comprising: (i) at least one compound selected from the group consisting of: a salt thereof, and a mixture thereof, (ii) at least one solid carrier, and (iii) one or more flavorings, with the proviso that the sum of components (i), (ii) and (iii), together with any further ingredients, is 100% by weight, based on the total amount of the foodstuff. 6. The method of claim 1 , wherein the compound is administered as a food supplement comprising: (i) at least one compound selected from the group consisting of: a salt thereof, and mixtures thereof, (ii) at least one solid carrier, and (iii) one or more flavorings, with the proviso that the sum of components (i), (ii) and (iii), together with any further ingredients, is 100% by weight, based on the total amount of the food supplement. 7. The method of claim 2 , wherein the medicament is a tablet or capsule. 8. The method of claim 3 , wherein the at least one solid carrier is selected from silicone dioxide, gum Arabic, and a maltodextrin having a DE value in the range of 5 to 20. 9. The method of claim 3 , wherein the at least one solid carrier has a mean particle size of 30 to 300 mm and a residual moisture content of less than or equal to 5% by weight. 10. The method of claim 5 , wherein the at least one solid carrier is selected from silicone dioxide, gum Arabic, and a maltodextrin having a DE value in the range of 5 to 20. 11. The method of claim 5 , wherein the at least one solid carrier has a mean particle size of 30 to 300 μm and a residual moisture content of less than or equal to 5% by weight. 12. The method of claim 5 , wherein the foodstuff further comprises: (iv) one or more sweeteners. 13. The method of claim 12 , wherein the foodstuff further comprises: (v) one or more thickeners. 14. The method of claim 5 , wherein the foodstuff is chewing gum comprising a water-insoluble component and a water-soluble component.

Assignees

Inventors

Classifications

  • Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents · CPC title

  • using additives (addition of substantially indigestible substances A23L33/21) · CPC title

  • Other dairy products · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • not hydrogenated in the hetero ring, e.g. flavones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10561633B2 cover?
The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood.
Who is the assignee on this patent?
Symrise Ag
What technology area does this patent fall under?
Primary CPC classification A61K31/352. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).